KZA 0.00% 8.0¢ kazia therapeutics limited

Sure, but Pax may be in competition with it.What if the P13K...

  1. 908 Posts.
    lightbulb Created with Sketch. 101
    Sure, but Pax may be in competition with it.
    What if the P13K inhibitor market evolves such that a drug which also inhibits brain mestastases becomes the SOC?
    (yes, making a big leap)
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.